Menu Back toS14-Forefront-of-Drug-Delivery-System-DDS-Technology

16th DIA Japan Annual Meeting 2019

Delivering Rational Medicine for All People in the Globe

[S14] Forefront of Drug Delivery System (DDS) Technology

Session Chair(s)

Mitsuru  Hashida, PhD

Mitsuru Hashida, PhD

  • Program-Specific Professor, Institute for Integrated Cell-Material Sciences
  • Kyoto University, Japan
The trend of drug development is shifting from small molecules to medium- to high molecules such as peptides, proteins and nucleic acids, but problems such as stability and permeability become major barriers to their practical use. DDS research is becoming active to solve the problem. In this session, pharmaceutical company and research institute introduce the latest research and challenges in developing such DDS technology. In addition, the regulatory authorities introduce the current status and issues of regulation, and the future prospects.


Kumiko  Sakai-Kato, PhD

Research on Evaluation of Innovative Nanomedicine, a Core Technology for DDS

Kumiko Sakai-Kato, PhD

  • Section Head, Division of Drugs
  • National Institute of Health Sciences, Japan
Hiroshi  Ishihara, PhD

Nano-DDS Resarch in Pharmaceutical Company

Hiroshi Ishihara, PhD

  • Director, Nanomedicine Research
  • Eisai, Co., Ltd., Japan
Kosuke  Ito, PhD

Kosuke Ito, PhD

  • Reviewer, Office of New Drug V
  • Pharmaceuticals and Medical Devices Agency (PMDA), Japan